Acquired Exon 14
MET
Mutation Associated With Resistance to Alectinib in a Patient With
ALK-
Rearranged NSCLC
JTO Clin Res Rep
.
2020 Aug 7;1(4):100082.
doi: 10.1016/j.jtocrr.2020.100082.
eCollection 2020 Nov.
Authors
Catherine Daniel
1
,
Celine Callens
2
,
Samia Melaabi
2
,
Ivan Bieche
2
,
Nicolas Girard
1
Affiliations
1
Oncology Department, Institut Curie, Paris, France.
2
Genetics Department Institut Curie, Paris, France.
PMID:
34589961
PMCID:
PMC8474206
DOI:
10.1016/j.jtocrr.2020.100082
No abstract available
Publication types
Case Reports